LYMPHOGENiX specializes in lymphatic vessel regeneration through proprietary cytokine cocktails that enhance lymphangiogenesis, targeting conditions such as heart failure, pulmonary fibrosis, and infertility. The company aims to improve patient vitality by restoring lymphatic function, which is critical for fluid balance and immune response.
Funding
Funding not disclosed
Founders
Product
Problem
Many diseases, including heart failure, pulmonary fibrosis, Alzheimer's, skin aging, and infertility, are linked to impaired lymphatic function, which is crucial for fluid balance, immune response, and tissue regeneration. Current treatments often fail to address the underlying lymphatic dysfunction, limiting their effectiveness in restoring overall patient vitality.
Solution
LYMPHOGENiX is developing proprietary cytokine cocktails designed to stimulate lymphatic vessel regeneration (lymphangiogenesis) and restore lymphatic function. Their technology aims to improve outcomes for a range of conditions by enhancing fluid clearance, immune cell trafficking, and tissue repair. The company offers tailored solutions, including cytokine cocktails for skin-aging clinics and pipeline management for CNS research, and collaborates on clinical studies for infertility treatment. By targeting the regeneration of lymphatic vessels, LYMPHOGENiX seeks to provide more effective treatments compared to traditional approaches.
Target Audience
The primary target audience includes patients suffering from heart failure, pulmonary fibrosis, Alzheimer's disease, skin aging, and infertility, as well as skin-aging clinics, CNS research institutions, and partners for clinical studies in infertility treatment.
Features
- Proprietary cytokine cocktails to stimulate lymphangiogenesis.
- FRF (fibroblast-rejuvenating factor) for skin-aging treatments, enhancing effectiveness compared to traditional fibroblast treatments.
- Research into Alzheimer's treatment focused on improving amyloid-β clearance through lymphatic regeneration.
- Heart failure treatment designed to improve cardiac function by generating more lymphatic vessels.
- Approach to pulmonary fibrosis focused on recovering fibrotic areas by activating lymphangiogenesis.
- Technology to rejuvenate fibroblasts, giving them strong lymphangiogenic effects.
- Proprietary injecting device for administration of fibroblasts or rejuvenated culture fluids.